I certainly have, especially those that treat a larger number of opioid patients. I think in many ways it’s a better drug than methadone. Easier to use in outpatient practice, and by patient report, less sedating. So with good controls, I’d say it’s a legit therapeutic option. And one that’s not that difficult to terminate when it’s no longer needed, or when you decide to try something else.
The ‘good controls’ part increasingly concerns me. I’ve observed a tendency to slack off on those controls as time passes, and the size of the patient group increases. The National Council (NCADD) just published this on the subject, based on data from the U of Maryland’s CESAR project.
In 2003 there were 20,000 patients on bupe. In six short years, that grew to 600,000. Anyone surprised that a significant amount is apparently being diverted to what’s politely termed ‘nonmedical uses’? And that this contributes to a growing number of accidental ODs and drug-related ER visits? There’s a saying among street drug users: ‘if it can be done, it will be done’. Translation: if there’s a way to subvert a system to gain access to potent drugs, addicts will find it.
No way around that — we just have to prepare for it. And apparently in future we need to do a better job.